Summary

The global Intracranial Embolization Coils market is projected to grow from US$ 955 million in 2025 to US$ 1445 million by 2032, at a CAGR of 6.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Intracranial Embolization Coils are implantable neurointerventional embolization devices delivered through microcatheters into intracranial aneurysms or other indicated neurovascular lesions to reduce or occlude blood flow through mechanical space filling, flow disruption, and thrombus formation. The products are primarily manufactured from highly radiopaque and biocompatible platinum or platinum-based alloys and are predominantly designed as detachable coil systems that permit controlled deployment, repositioning, and release under fluoroscopic guidance. Commercial configurations cover three-dimensional complex and helical geometries, multiple softness grades, secondary diameters, implant lengths, and primary coil profiles, with product portfolios typically optimized for framing, filling, finishing, or multipurpose use. Technology platforms include conventional bare platinum coils as well as hydrogel-enhanced and fiber-enhanced designs intended to improve packing performance, thrombogenic response, or mechanical characteristics. Intracranial Embolization Coils are used predominantly in endovascular treatment of intracranial aneurysms and also address selected neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulas where coil embolization is clinically indicated.
Key Findings
Detachable platinum and platinum-alloy coils remain the mainstream commercial format for intracranial aneurysm embolization
Product differentiation increasingly centers on softness, shape stability, packing efficiency, detachment reliability, and microcatheter compatibility
Asia Pacific is becoming increasingly important as domestic manufacturing, procedure penetration, and international market access expand
Competition is shifting from individual coil products toward broader neurovascular treatment portfolios and integrated procedural solutions
Market Trends
Intracranial Embolization Coils are evolving from relatively standardized metallic implants toward increasingly differentiated systems optimized for specific stages of aneurysm packing and different lesion morphologies. Manufacturers are expanding three-dimensional complex shapes, ultra-soft finishing coils, higher-volume coil structures, and broader diameter and length portfolios to improve wall conformity, frame stability, and packing efficiency while limiting radial stress on the aneurysm wall. Hydrogel-enhanced and fiber-enhanced technologies provide additional routes to increase effective filling volume or thrombogenic performance, while lower-profile delivery systems and faster, more predictable detachment mechanisms improve procedural control. At the same time, coil embolization is increasingly used within a broader lesion-specific treatment framework that also incorporates balloon assistance, coil-assist stents, flow diversion, and intrasaccular devices. This is reinforcing demand for coil portfolios that can address framing, filling, and finishing requirements rather than relying on a limited set of general-purpose products.
Market Dynamics
Drivers
Demand is supported by the established clinical role of endovascular treatment for intracranial aneurysms, continued expansion of neurointerventional capabilities, greater availability of advanced vascular imaging, and wider access to specialized stroke and cerebrovascular centers. Increasing treatment penetration in emerging healthcare systems is particularly important because coil procedures require an established neurointerventional infrastructure and tend to expand as physician training, catheter laboratory capacity, and reimbursement coverage improve. Product innovation is also supporting replacement and portfolio expansion as physicians seek softer coils, stable framing structures, higher packing efficiency, and more predictable delivery and detachment performance.
Restraints
The market faces pricing pressure from centralized and volume-based procurement, hospital cost controls, and stronger competition among clinically comparable coil systems. These factors are particularly relevant in China and other price-sensitive healthcare markets, where increasing domestic supply can reduce average selling prices even as procedure volumes rise. Clinical substitution also constrains addressable demand in selected aneurysm anatomies, as flow diverters and intrasaccular devices provide alternative treatment strategies. In addition, precious-metal inputs, stringent quality control, sterilization, regulatory compliance, and high commercial support requirements limit the extent to which manufacturers can offset price reductions through basic manufacturing cost savings.
Opportunities
The most important opportunities are concentrated in broader treatment access, product specialization, and geographic expansion. Emerging neurointerventional markets offer incremental demand as hospitals establish advanced cerebrovascular programs, while manufacturers with internationally approved coil platforms can leverage an existing product base across multiple regulatory jurisdictions. Further opportunities exist in small and complex aneurysm treatment, ultra-soft finishing products, high-volume packing designs, hydrogel or fiber-enhanced coils, and coil systems engineered for low-profile microcatheters. Chinese manufacturers are also moving from domestic substitution toward international commercialization, creating additional opportunities for competitively priced products with broader regulatory coverage.
Challenges
Long-term competitive success depends on consistent implant quality, precise mechanical performance, reliable detachment, and a strong clinical evidence base rather than manufacturing scale alone. Coil behavior is highly sensitive to aneurysm morphology, catheter position, physician technique, and interaction with adjunctive devices, making product performance difficult to standardize through simple dimensional specifications. Regulatory requirements for implantable Class III neurovascular devices remain demanding, and entry into major international markets requires sustained investment in clinical evidence, quality systems, post-market surveillance, and physician education. Manufacturers must also manage portfolio complexity because commercially competitive platforms increasingly require multiple shapes, softness levels, diameters, lengths, and procedural roles.
Industry Chain Analysis
The upstream industry chain centers on high-purity platinum and platinum-based alloy wire, stainless steel and other delivery-system materials, polymer fibers, hydrogel or other functional materials, microcatheter-compatible components, packaging materials, and sterilization services. Raw material value alone does not determine product economics. Critical value creation occurs in micro-scale wire processing, primary coil winding, secondary shape setting, mechanical design, stretch-resistance structures, detachment-junction manufacturing, radiopacity control, dimensional consistency, sterile assembly, and verification of delivery performance. These processes require tight tolerances and quality systems appropriate for permanent neurovascular implants.
Midstream manufacturers integrate implant design, delivery systems, detachment technology, manufacturing validation, regulatory registration, and clinical support into commercially viable coil platforms. Downstream demand comes primarily from tertiary hospitals, comprehensive stroke centers, neurosurgical centers, and neurointerventional departments, with procurement structures varying from direct hospital contracting to distributors and centralized purchasing programs. Profitability is therefore influenced not only by precious-metal and production costs but also by research and development, regulatory compliance, clinical education, distribution, inventory depth across numerous specifications, and market-access expenditure. Manufacturers with broad specification coverage and integrated neurovascular portfolios can generally achieve greater account penetration and operating leverage than suppliers dependent on a limited number of coil configurations.
Segment Insights
By Coil Technology, bare platinum and platinum-alloy coils remain the largest segment by volume because they provide an established combination of radiopacity, biocompatibility, mechanical flexibility, and broad clinical familiarity. Hydrogel-enhanced coils represent a differentiated higher-value segment focused on increasing effective packing volume, while fiber-enhanced products use additional polymer structures to modify thrombogenic or mechanical characteristics. The competitive distinction is increasingly based on clinical handling and packing performance rather than base metal composition alone, and advanced designs are expected to gain relevance in procedures where packing density and residual cavity management are particularly important.
By Primary Procedural Role, framing, filling, finishing, and multipurpose coils form a complementary treatment sequence rather than independent clinical applications. Framing products emphasize three-dimensional stability and aneurysm-wall conformity, while filling coils balance volume efficiency and softness. Finishing products favor very low radial force and the ability to occupy small residual spaces near the end of the procedure. Multipurpose platforms seek to reduce procedural complexity by allowing a broader range of uses from initial frame formation through final packing. This segmentation is increasingly important for product portfolio design because a competitive manufacturer must address the full procedural workflow rather than a single coil specification.
Downstream Market Opportunities
Intracranial aneurysm treatment constitutes the principal downstream opportunity, with demand concentrated in neurointerventional and neurosurgical centers capable of performing catheter-based cerebrovascular procedures. Additional demand arises from selected arteriovenous malformations, arteriovenous fistulas, and other neurovascular lesions where coil embolization is appropriate. Future opportunities are linked less to expansion into unrelated indications than to greater diagnosis and treatment penetration, increased access to specialist centers, and broader use of endovascular therapy in emerging markets. Complex aneurysms also create demand for larger and more differentiated coil inventories because treatment frequently requires combinations of framing, filling, and finishing products together with adjunctive stents or balloons.
Regional Insights
North America remains a major high-value market, supported by mature neurointerventional infrastructure, extensive adoption of premium detachable coil platforms, and broad availability of adjunctive aneurysm-treatment technologies. Europe is similarly mature but exhibits greater country-level variation in reimbursement and procurement. Japan maintains a technologically sophisticated market with established domestic and international manufacturers, while other developed Asian markets continue to adopt advanced coil systems within expanding neurovascular treatment programs.
Asia Pacific is becoming increasingly important to incremental demand, with China representing a distinctive combination of expanding procedure penetration, domestic product substitution, centralized procurement, and accelerating manufacturer internationalization. Volume-based procurement has increased pricing pressure for established coil categories but has also improved access for competitive domestic products and encouraged manufacturers to optimize cost structures. Chinese suppliers are increasingly obtaining registrations and commercializing coil systems outside their home market, while Southeast Asia, India, the Middle East, and Latin America offer longer-term opportunities as neurointerventional infrastructure and specialist training expand.
Competitive Landscape Analysis
Competition in Intracranial Embolization Coils is led by multinational neurovascular platforms and specialist manufacturers with established detachable-coil technologies, extensive specification portfolios, regulatory coverage, and physician relationships. Stryker Corporation, Medtronic plc, Johnson & Johnson, Terumo Corporation, Penumbra, Inc., BALT SAS, and Kaneka Corporation compete through differentiated coil geometry, softness, packing characteristics, detachment systems, and integration with broader aneurysm-treatment portfolios, while Genesis MedTech Group provides an additional Asia-based platform. Chinese manufacturers including Wallaby Medical Holding, Inc., MicroPort NeuroScientific Corporation, Zylox-Tonbridge Medical Technology Co., Ltd., Shanghai HeartCare Medical Technology Corporation Limited, Peijia Medical Limited, Beijing Taijieweiye Technology Co., Ltd., Weigao Holding Co., Ltd., and Shunmei Medical Co., Ltd. are strengthening domestic commercialization and, in several cases, expanding international registrations and distribution. Competitive advantage is increasingly determined by full-procedure product coverage, clinical handling characteristics, reliable manufacturing, hospital access, regulatory execution, and the ability to balance procurement-driven pricing pressure with product innovation and operating efficiency.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Intracranial Embolization Coils market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Stryker Corporation
Medtronic plc
Johnson & Johnson
Terumo Corporation
Penumbra, Inc.
BALT SAS
Kaneka Corporation
Genesis MedTech Group
Wallaby Medical Holding, Inc.
MicroPort NeuroScientific Corporation
Zylox-Tonbridge Medical Technology Co., Ltd.
Shanghai HeartCare Medical Technology Corporation Limited
Peijia Medical Limited
Beijing Taijieweiye Technology Co., Ltd.
Weigao Holding Co., Ltd.
Shunmei Medical Co., Ltd.
Segment by Type
Bare Platinum Coils
Hydrogel-Enhanced Coils
Fiber-Enhanced Coils
Others
Segment by Coil Shape
Three-Dimensional Complex Coils
Helical Coils
Others
Segment by Detachment Method
Mechanical Detachment Coils
Electrolytic Detachment Coils
Others
Segment by Stretch Resistance Structure
Monofilament Reinforced Coils
Multifilament Reinforced Coils
Others
Segment by Application
Intracranial Aneurysm
Arteriovenous Malformation (AVM)
Cerebral Infarction
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Intracranial Embolization Coils study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Intracranial Embolization Coils: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Intracranial Embolization Coils Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Bare Platinum Coils
1.2.3 Hydrogel-Enhanced Coils
1.2.4 Fiber-Enhanced Coils
1.2.5 Others
1.3 Market Segmentation by Coil Shape
1.3.1 Global Intracranial Embolization Coils Market Size by Coil Shape, 2021 vs 2025 vs 2032
1.3.2 Three-Dimensional Complex Coils
1.3.3 Helical Coils
1.3.4 Others
1.4 Market Segmentation by Detachment Method
1.4.1 Global Intracranial Embolization Coils Market Size by Detachment Method, 2021 vs 2025 vs 2032
1.4.2 Mechanical Detachment Coils
1.4.3 Electrolytic Detachment Coils
1.4.4 Others
1.5 Market Segmentation by Stretch Resistance Structure
1.5.1 Global Intracranial Embolization Coils Market Size by Stretch Resistance Structure, 2021 vs 2025 vs 2032
1.5.2 Monofilament Reinforced Coils
1.5.3 Multifilament Reinforced Coils
1.5.4 Others
1.6 Market Segmentation by Application
1.6.1 Global Intracranial Embolization Coils Market Size by Application, 2021 vs 2025 vs 2032
1.6.2 Intracranial Aneurysm
1.6.3 Arteriovenous Malformation (AVM)
1.6.4 Cerebral Infarction
1.6.5 Others
1.7 Assumptions and Limitations
1.8 Study Objectives
1.9 Years Considered

2 Executive Summary
2.1 Global Intracranial Embolization Coils Revenue Estimates and Forecasts (2021-2032)
2.2 Global Intracranial Embolization Coils Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Intracranial Embolization Coils Sales Estimates and Forecasts (2021-2032)
2.4 Global Intracranial Embolization Coils Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Intracranial Embolization Coils Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Intracranial Embolization Coils Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Bare Platinum Coils: Market Share by Key Manufacturers
3.5.2 Hydrogel-Enhanced Coils: Market Share by Key Manufacturers
3.5.3 Fiber-Enhanced Coils: Market Share by Key Manufacturers
3.5.4 Others: Market Share by Key Manufacturers
3.6 Global Intracranial Embolization Coils Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Intracranial Embolization Coils Sales Performance by Type
4.1.1 Global Intracranial Embolization Coils Sales Volume by Type (2021-2032)
4.1.2 Global Intracranial Embolization Coils Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Intracranial Embolization Coils Sales Performance by Coil Shape
4.2.1 Global Intracranial Embolization Coils Sales Volume by Coil Shape (2021-2032)
4.2.2 Global Intracranial Embolization Coils Revenue by Coil Shape (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Coil Shape (2021-2032)
4.3 Global Intracranial Embolization Coils Sales Performance by Detachment Method
4.3.1 Global Intracranial Embolization Coils Sales Volume by Detachment Method (2021-2032)
4.3.2 Global Intracranial Embolization Coils Revenue by Detachment Method (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Detachment Method (2021-2032)
4.4 Global Intracranial Embolization Coils Sales Performance by Stretch Resistance Structure
4.4.1 Global Intracranial Embolization Coils Sales Volume by Stretch Resistance Structure (2021-2032)
4.4.2 Global Intracranial Embolization Coils Revenue by Stretch Resistance Structure (2021-2032)
4.4.3 Global Average Selling Price (ASP) Trends by Stretch Resistance Structure (2021-2032)
4.5 Product Technology Differentiation
4.6 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.6.1 High-Growth Niches and Adoption Drivers
4.6.2 Profitability Hotspots and Cost Drivers
4.6.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Intracranial Embolization Coils Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Intracranial Embolization Coils Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Intracranial Embolization Coils Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Intracranial Embolization Coils Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Intracranial Embolization Coils Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Intracranial Embolization Coils Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Intracranial Embolization Coils Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Intracranial Embolization Coils Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Intracranial Embolization Coils Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Intracranial Embolization Coils Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Intracranial Embolization Coils Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Intracranial Embolization Coils Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Stryker Corporation
11.1.1 Stryker Corporation Corporation Information
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.1.4 Stryker Corporation Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Stryker Corporation Intracranial Embolization Coils Sales by Product in 2025
11.1.6 Stryker Corporation Intracranial Embolization Coils Sales by Application in 2025
11.1.7 Stryker Corporation Intracranial Embolization Coils Sales by Geographic Area in 2025
11.1.8 Stryker Corporation Intracranial Embolization Coils SWOT Analysis
11.1.9 Stryker Corporation Recent Developments
11.2 Medtronic plc
11.2.1 Medtronic plc Corporation Information
11.2.2 Medtronic plc Business Overview
11.2.3 Medtronic plc Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.2.4 Medtronic plc Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Medtronic plc Intracranial Embolization Coils Sales by Product in 2025
11.2.6 Medtronic plc Intracranial Embolization Coils Sales by Application in 2025
11.2.7 Medtronic plc Intracranial Embolization Coils Sales by Geographic Area in 2025
11.2.8 Medtronic plc Intracranial Embolization Coils SWOT Analysis
11.2.9 Medtronic plc Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.3.4 Johnson & Johnson Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Johnson & Johnson Intracranial Embolization Coils Sales by Product in 2025
11.3.6 Johnson & Johnson Intracranial Embolization Coils Sales by Application in 2025
11.3.7 Johnson & Johnson Intracranial Embolization Coils Sales by Geographic Area in 2025
11.3.8 Johnson & Johnson Intracranial Embolization Coils SWOT Analysis
11.3.9 Johnson & Johnson Recent Developments
11.4 Terumo Corporation
11.4.1 Terumo Corporation Corporation Information
11.4.2 Terumo Corporation Business Overview
11.4.3 Terumo Corporation Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.4.4 Terumo Corporation Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Terumo Corporation Intracranial Embolization Coils Sales by Product in 2025
11.4.6 Terumo Corporation Intracranial Embolization Coils Sales by Application in 2025
11.4.7 Terumo Corporation Intracranial Embolization Coils Sales by Geographic Area in 2025
11.4.8 Terumo Corporation Intracranial Embolization Coils SWOT Analysis
11.4.9 Terumo Corporation Recent Developments
11.5 Penumbra, Inc.
11.5.1 Penumbra, Inc. Corporation Information
11.5.2 Penumbra, Inc. Business Overview
11.5.3 Penumbra, Inc. Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.5.4 Penumbra, Inc. Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Penumbra, Inc. Intracranial Embolization Coils Sales by Product in 2025
11.5.6 Penumbra, Inc. Intracranial Embolization Coils Sales by Application in 2025
11.5.7 Penumbra, Inc. Intracranial Embolization Coils Sales by Geographic Area in 2025
11.5.8 Penumbra, Inc. Intracranial Embolization Coils SWOT Analysis
11.5.9 Penumbra, Inc. Recent Developments
11.6 BALT SAS
11.6.1 BALT SAS Corporation Information
11.6.2 BALT SAS Business Overview
11.6.3 BALT SAS Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.6.4 BALT SAS Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 BALT SAS Recent Developments
11.7 Kaneka Corporation
11.7.1 Kaneka Corporation Corporation Information
11.7.2 Kaneka Corporation Business Overview
11.7.3 Kaneka Corporation Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.7.4 Kaneka Corporation Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Kaneka Corporation Recent Developments
11.8 Genesis MedTech Group
11.8.1 Genesis MedTech Group Corporation Information
11.8.2 Genesis MedTech Group Business Overview
11.8.3 Genesis MedTech Group Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.8.4 Genesis MedTech Group Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Genesis MedTech Group Recent Developments
11.9 Wallaby Medical Holding, Inc.
11.9.1 Wallaby Medical Holding, Inc. Corporation Information
11.9.2 Wallaby Medical Holding, Inc. Business Overview
11.9.3 Wallaby Medical Holding, Inc. Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.9.4 Wallaby Medical Holding, Inc. Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Wallaby Medical Holding, Inc. Recent Developments
11.10 MicroPort NeuroScientific Corporation
11.10.1 MicroPort NeuroScientific Corporation Corporation Information
11.10.2 MicroPort NeuroScientific Corporation Business Overview
11.10.3 MicroPort NeuroScientific Corporation Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.10.4 MicroPort NeuroScientific Corporation Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 MicroPort NeuroScientific Corporation Recent Developments
11.11 Zylox-Tonbridge Medical Technology Co., Ltd.
11.11.1 Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
11.11.2 Zylox-Tonbridge Medical Technology Co., Ltd. Business Overview
11.11.3 Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.11.4 Zylox-Tonbridge Medical Technology Co., Ltd. Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
11.12 Shanghai HeartCare Medical Technology Corporation Limited
11.12.1 Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
11.12.2 Shanghai HeartCare Medical Technology Corporation Limited Business Overview
11.12.3 Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.12.4 Shanghai HeartCare Medical Technology Corporation Limited Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
11.13 Peijia Medical Limited
11.13.1 Peijia Medical Limited Corporation Information
11.13.2 Peijia Medical Limited Business Overview
11.13.3 Peijia Medical Limited Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.13.4 Peijia Medical Limited Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Peijia Medical Limited Recent Developments
11.14 Beijing Taijieweiye Technology Co., Ltd.
11.14.1 Beijing Taijieweiye Technology Co., Ltd. Corporation Information
11.14.2 Beijing Taijieweiye Technology Co., Ltd. Business Overview
11.14.3 Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.14.4 Beijing Taijieweiye Technology Co., Ltd. Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Beijing Taijieweiye Technology Co., Ltd. Recent Developments
11.15 Weigao Holding Co., Ltd.
11.15.1 Weigao Holding Co., Ltd. Corporation Information
11.15.2 Weigao Holding Co., Ltd. Business Overview
11.15.3 Weigao Holding Co., Ltd. Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.15.4 Weigao Holding Co., Ltd. Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Weigao Holding Co., Ltd. Recent Developments
11.16 Shunmei Medical Co., Ltd.
11.16.1 Shunmei Medical Co., Ltd. Corporation Information
11.16.2 Shunmei Medical Co., Ltd. Business Overview
11.16.3 Shunmei Medical Co., Ltd. Intracranial Embolization Coils Product Models, Descriptions and Specifications
11.16.4 Shunmei Medical Co., Ltd. Intracranial Embolization Coils Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 Shunmei Medical Co., Ltd. Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Intracranial Embolization Coils Industry Chain
12.2 Intracranial Embolization Coils Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Intracranial Embolization Coils Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Intracranial Embolization Coils Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Intracranial Embolization Coils Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Intracranial Embolization Coils Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Intracranial Embolization Coils Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Intracranial Embolization Coils Market Size Growth Rate by Coil Shape, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Intracranial Embolization Coils Market Size Growth Rate by Detachment Method, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Intracranial Embolization Coils Market Size Growth Rate by Stretch Resistance Structure, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Intracranial Embolization Coils Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Intracranial Embolization Coils Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 7. Global Intracranial Embolization Coils Revenue by Region (US$ Million), 2021-2026
Table 8. Global Intracranial Embolization Coils Revenue by Region (US$ Million), 2027-2032
Table 9. Global Intracranial Embolization Coils Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 10. Global Intracranial Embolization Coils Sales by Region (K Units), 2021-2026
Table 11. Global Intracranial Embolization Coils Sales by Region (K Units), 2027-2032
Table 12. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 13. Global Intracranial Embolization Coils Sales by Manufacturers (K Units), 2021-2026
Table 14. Global Intracranial Embolization Coils Sales Share by Manufacturers (2021-2026)
Table 15. Global Intracranial Embolization Coils Revenue by Manufacturers (US$ Million), 2021-2026
Table 16. Global Intracranial Embolization Coils Revenue-Based Market Share by Manufacturers (2021-2026)
Table 17. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 18. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Intracranial Embolization Coils Revenue, 2025
Table 19. Global Intracranial Embolization Coils Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 20. Global Intracranial Embolization Coils Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 21. Key Manufacturers Intracranial Embolization Coils Manufacturing Base and Headquarters
Table 22. Global Intracranial Embolization Coils Market Concentration Ratio (CR5)
Table 23. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Intracranial Embolization Coils Sales Volume by Type (K Units), 2021-2026
Table 26. Global Intracranial Embolization Coils Sales Volume by Type (K Units), 2027-2032
Table 27. Global Intracranial Embolization Coils Revenue by Type (US$ Million), 2021-2026
Table 28. Global Intracranial Embolization Coils Revenue by Type (US$ Million), 2027-2032
Table 29. Global Intracranial Embolization Coils Sales Volume by Coil Shape (K Units), 2021-2026
Table 30. Global Intracranial Embolization Coils Sales Volume by Coil Shape (K Units), 2027-2032
Table 31. Global Intracranial Embolization Coils Revenue by Coil Shape (US$ Million), 2021-2026
Table 32. Global Intracranial Embolization Coils Revenue by Coil Shape (US$ Million), 2027-2032
Table 33. Global Intracranial Embolization Coils Sales Volume by Detachment Method (K Units), 2021-2026
Table 34. Global Intracranial Embolization Coils Sales Volume by Detachment Method (K Units), 2027-2032
Table 35. Global Intracranial Embolization Coils Revenue by Detachment Method (US$ Million), 2021-2026
Table 36. Global Intracranial Embolization Coils Revenue by Detachment Method (US$ Million), 2027-2032
Table 37. Global Intracranial Embolization Coils Sales Volume by Stretch Resistance Structure (K Units), 2021-2026
Table 38. Global Intracranial Embolization Coils Sales Volume by Stretch Resistance Structure (K Units), 2027-2032
Table 39. Global Intracranial Embolization Coils Revenue by Stretch Resistance Structure (US$ Million), 2021-2026
Table 40. Global Intracranial Embolization Coils Revenue by Stretch Resistance Structure (US$ Million), 2027-2032
Table 41. Technical Specifications by Key Product Type
Table 42. Global Intracranial Embolization Coils Sales by Application (K Units), 2021-2026
Table 43. Global Intracranial Embolization Coils Sales by Application (K Units), 2027-2032
Table 44. Intracranial Embolization Coils High-Growth Sectors Demand CAGR (2026-2032)
Table 45. Global Intracranial Embolization Coils Revenue by Application (US$ Million), 2021-2026
Table 46. Global Intracranial Embolization Coils Revenue by Application (US$ Million), 2027-2032
Table 47. Top Customers by Region
Table 48. Top Customers by Application
Table 49. North America Intracranial Embolization Coils Growth Accelerators and Market Barriers
Table 50. North America Intracranial Embolization Coils Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 51. North America Intracranial Embolization Coils Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Europe Intracranial Embolization Coils Growth Accelerators and Market Barriers
Table 53. Europe Intracranial Embolization Coils Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Europe Intracranial Embolization Coils Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 55. Asia-Pacific Intracranial Embolization Coils Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 56. Asia-Pacific Intracranial Embolization Coils Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 57. Asia-Pacific Intracranial Embolization Coils Growth Accelerators and Market Barriers
Table 58. Southeast Asia Intracranial Embolization Coils Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 59. Central and South America Intracranial Embolization Coils Investment Opportunities and Key Challenges
Table 60. Central and South America Intracranial Embolization Coils Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 61. Middle East and Africa Intracranial Embolization Coils Investment Opportunities and Key Challenges
Table 62. Middle East and Africa Intracranial Embolization Coils Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 63. Stryker Corporation Corporation Information
Table 64. Stryker Corporation Description and Major Businesses
Table 65. Stryker Corporation Product Models, Descriptions and Specifications
Table 66. Stryker Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 67. Stryker Corporation Sales Value Proportion by Product in 2025
Table 68. Stryker Corporation Sales Value Proportion by Application in 2025
Table 69. Stryker Corporation Sales Value Proportion by Geographic Area in 2025
Table 70. Stryker Corporation Intracranial Embolization Coils SWOT Analysis
Table 71. Stryker Corporation Recent Developments
Table 72. Medtronic plc Corporation Information
Table 73. Medtronic plc Description and Major Businesses
Table 74. Medtronic plc Product Models, Descriptions and Specifications
Table 75. Medtronic plc Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Medtronic plc Sales Value Proportion by Product in 2025
Table 77. Medtronic plc Sales Value Proportion by Application in 2025
Table 78. Medtronic plc Sales Value Proportion by Geographic Area in 2025
Table 79. Medtronic plc Intracranial Embolization Coils SWOT Analysis
Table 80. Medtronic plc Recent Developments
Table 81. Johnson & Johnson Corporation Information
Table 82. Johnson & Johnson Description and Major Businesses
Table 83. Johnson & Johnson Product Models, Descriptions and Specifications
Table 84. Johnson & Johnson Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Johnson & Johnson Sales Value Proportion by Product in 2025
Table 86. Johnson & Johnson Sales Value Proportion by Application in 2025
Table 87. Johnson & Johnson Sales Value Proportion by Geographic Area in 2025
Table 88. Johnson & Johnson Intracranial Embolization Coils SWOT Analysis
Table 89. Johnson & Johnson Recent Developments
Table 90. Terumo Corporation Corporation Information
Table 91. Terumo Corporation Description and Major Businesses
Table 92. Terumo Corporation Product Models, Descriptions and Specifications
Table 93. Terumo Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Terumo Corporation Sales Value Proportion by Product in 2025
Table 95. Terumo Corporation Sales Value Proportion by Application in 2025
Table 96. Terumo Corporation Sales Value Proportion by Geographic Area in 2025
Table 97. Terumo Corporation Intracranial Embolization Coils SWOT Analysis
Table 98. Terumo Corporation Recent Developments
Table 99. Penumbra, Inc. Corporation Information
Table 100. Penumbra, Inc. Description and Major Businesses
Table 101. Penumbra, Inc. Product Models, Descriptions and Specifications
Table 102. Penumbra, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Penumbra, Inc. Sales Value Proportion by Product in 2025
Table 104. Penumbra, Inc. Sales Value Proportion by Application in 2025
Table 105. Penumbra, Inc. Sales Value Proportion by Geographic Area in 2025
Table 106. Penumbra, Inc. Intracranial Embolization Coils SWOT Analysis
Table 107. Penumbra, Inc. Recent Developments
Table 108. BALT SAS Corporation Information
Table 109. BALT SAS Description and Major Businesses
Table 110. BALT SAS Product Models, Descriptions and Specifications
Table 111. BALT SAS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. BALT SAS Recent Developments
Table 113. Kaneka Corporation Corporation Information
Table 114. Kaneka Corporation Description and Major Businesses
Table 115. Kaneka Corporation Product Models, Descriptions and Specifications
Table 116. Kaneka Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Kaneka Corporation Recent Developments
Table 118. Genesis MedTech Group Corporation Information
Table 119. Genesis MedTech Group Description and Major Businesses
Table 120. Genesis MedTech Group Product Models, Descriptions and Specifications
Table 121. Genesis MedTech Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Genesis MedTech Group Recent Developments
Table 123. Wallaby Medical Holding, Inc. Corporation Information
Table 124. Wallaby Medical Holding, Inc. Description and Major Businesses
Table 125. Wallaby Medical Holding, Inc. Product Models, Descriptions and Specifications
Table 126. Wallaby Medical Holding, Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Wallaby Medical Holding, Inc. Recent Developments
Table 128. MicroPort NeuroScientific Corporation Corporation Information
Table 129. MicroPort NeuroScientific Corporation Description and Major Businesses
Table 130. MicroPort NeuroScientific Corporation Product Models, Descriptions and Specifications
Table 131. MicroPort NeuroScientific Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. MicroPort NeuroScientific Corporation Recent Developments
Table 133. Zylox-Tonbridge Medical Technology Co., Ltd. Corporation Information
Table 134. Zylox-Tonbridge Medical Technology Co., Ltd. Description and Major Businesses
Table 135. Zylox-Tonbridge Medical Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 136. Zylox-Tonbridge Medical Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Zylox-Tonbridge Medical Technology Co., Ltd. Recent Developments
Table 138. Shanghai HeartCare Medical Technology Corporation Limited Corporation Information
Table 139. Shanghai HeartCare Medical Technology Corporation Limited Description and Major Businesses
Table 140. Shanghai HeartCare Medical Technology Corporation Limited Product Models, Descriptions and Specifications
Table 141. Shanghai HeartCare Medical Technology Corporation Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments
Table 143. Peijia Medical Limited Corporation Information
Table 144. Peijia Medical Limited Description and Major Businesses
Table 145. Peijia Medical Limited Product Models, Descriptions and Specifications
Table 146. Peijia Medical Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Peijia Medical Limited Recent Developments
Table 148. Beijing Taijieweiye Technology Co., Ltd. Corporation Information
Table 149. Beijing Taijieweiye Technology Co., Ltd. Description and Major Businesses
Table 150. Beijing Taijieweiye Technology Co., Ltd. Product Models, Descriptions and Specifications
Table 151. Beijing Taijieweiye Technology Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Beijing Taijieweiye Technology Co., Ltd. Recent Developments
Table 153. Weigao Holding Co., Ltd. Corporation Information
Table 154. Weigao Holding Co., Ltd. Description and Major Businesses
Table 155. Weigao Holding Co., Ltd. Product Models, Descriptions and Specifications
Table 156. Weigao Holding Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Weigao Holding Co., Ltd. Recent Developments
Table 158. Shunmei Medical Co., Ltd. Corporation Information
Table 159. Shunmei Medical Co., Ltd. Description and Major Businesses
Table 160. Shunmei Medical Co., Ltd. Product Models, Descriptions and Specifications
Table 161. Shunmei Medical Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Shunmei Medical Co., Ltd. Recent Developments
Table 163. Key Raw Materials Distribution
Table 164. Raw Materials Key Suppliers
Table 165. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 166. Milestones in Production Technology Evolution
Table 167. Distributors List
Table 168. Market Trends and Market Evolution
Table 169. Market Drivers and Opportunities
Table 170. Market Challenges, Risks, and Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources

List of Figures
Figure 1. Intracranial Embolization Coils Product Picture
Figure 2. Global Intracranial Embolization Coils Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Bare Platinum Coils Product Picture
Figure 4. Hydrogel-Enhanced Coils Product Picture
Figure 5. Fiber-Enhanced Coils Product Picture
Figure 6. Others Product Picture
Figure 7. Global Intracranial Embolization Coils Market Size Growth Rate by Coil Shape, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Three-Dimensional Complex Coils Product Picture
Figure 9. Helical Coils Product Picture
Figure 10. Others Product Picture
Figure 11. Global Intracranial Embolization Coils Market Size Growth Rate by Detachment Method, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Mechanical Detachment Coils Product Picture
Figure 13. Electrolytic Detachment Coils Product Picture
Figure 14. Others Product Picture
Figure 15. Global Intracranial Embolization Coils Market Size Growth Rate by Stretch Resistance Structure, 2021 vs 2025 vs 2032 (US$ Million)
Figure 16. Monofilament Reinforced Coils Product Picture
Figure 17. Multifilament Reinforced Coils Product Picture
Figure 18. Others Product Picture
Figure 19. Global Intracranial Embolization Coils Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 20. Intracranial Aneurysm
Figure 21. Arteriovenous Malformation (AVM)
Figure 22. Cerebral Infarction
Figure 23. Others
Figure 24. Intracranial Embolization Coils Report Years Considered
Figure 25. Global Intracranial Embolization Coils Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 26. Global Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 27. Global Intracranial Embolization Coils Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 28. Global Intracranial Embolization Coils Revenue-Based Market Share by Region (2021-2032)
Figure 29. Global Intracranial Embolization Coils Sales (K Units), 2021-2032
Figure 30. Global Intracranial Embolization Coils Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 31. Global Intracranial Embolization Coils Sales Market Share by Region (2021-2032)
Figure 32. Top 5 and Top 10 Manufacturers Intracranial Embolization Coils Sales Volume Market Share in 2025
Figure 33. Global Intracranial Embolization Coils Revenue-Based Market Share Ranking (2025)
Figure 34. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 35. Bare Platinum Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 36. Hydrogel-Enhanced Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 37. Fiber-Enhanced Coils Revenue-Based Market Share by Manufacturer in 2025
Figure 38. Others Revenue-Based Market Share by Manufacturer in 2025
Figure 39. Global Intracranial Embolization Coils Sales Volume-Based Market Share by Type (2021-2032)
Figure 40. Global Intracranial Embolization Coils Revenue-Based Market Share by Type (2021-2032)
Figure 41. Global Intracranial Embolization Coils ASP by Type (US$/Unit), 2021-2032
Figure 42. Global Intracranial Embolization Coils Sales Volume-Based Market Share by Coil Shape (2021-2032)
Figure 43. Global Intracranial Embolization Coils Revenue-Based Market Share by Coil Shape (2021-2032)
Figure 44. Global Intracranial Embolization Coils ASP by Coil Shape (US$/Unit), 2021-2032
Figure 45. Global Intracranial Embolization Coils Sales Volume-Based Market Share by Detachment Method (2021-2032)
Figure 46. Global Intracranial Embolization Coils Revenue-Based Market Share by Detachment Method (2021-2032)
Figure 47. Global Intracranial Embolization Coils ASP by Detachment Method (US$/Unit), 2021-2032
Figure 48. Global Intracranial Embolization Coils Sales Volume-Based Market Share by Stretch Resistance Structure (2021-2032)
Figure 49. Global Intracranial Embolization Coils Revenue-Based Market Share by Stretch Resistance Structure (2021-2032)
Figure 50. Global Intracranial Embolization Coils ASP by Stretch Resistance Structure (US$/Unit), 2021-2032
Figure 51. Global Intracranial Embolization Coils Sales Market Share by Application (2021-2032)
Figure 52. Global Intracranial Embolization Coils Revenue-Based Market Share by Application (2021-2032)
Figure 53. Global Intracranial Embolization Coils ASP by Application (US$/Unit), 2021-2032
Figure 54. North America Intracranial Embolization Coils Sales YoY (K Units), 2021-2032
Figure 55. North America Intracranial Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 56. North America Top 5 Manufacturers Intracranial Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 57. North America Intracranial Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 58. North America Intracranial Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. US Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 60. Canada Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 61. Mexico Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 62. Europe Intracranial Embolization Coils Sales YoY (K Units), 2021-2032
Figure 63. Europe Intracranial Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 64. Europe Top 5 Manufacturers Intracranial Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 65. Europe Intracranial Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 66. Europe Intracranial Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 67. Germany Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 68. France Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 69. U.K. Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 70. Italy Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 71. Russia Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 72. Asia-Pacific Intracranial Embolization Coils Sales YoY (K Units), 2021-2032
Figure 73. Asia-Pacific Intracranial Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 74. Asia-Pacific Top 8 Manufacturers Intracranial Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 75. Asia-Pacific Intracranial Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 76. Asia-Pacific Intracranial Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. Indonesia Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 78. Japan Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 79. South Korea Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 80. China Taiwan Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 81. India Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 82. Central and South America Intracranial Embolization Coils Sales YoY (K Units), 2021-2032
Figure 83. Central and South America Intracranial Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 84. Central and South America Top 5 Manufacturers Intracranial Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 85. Central and South America Intracranial Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 86. Central and South America Intracranial Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 87. Brazil Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 88. Argentina Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 89. Middle East, and Africa Intracranial Embolization Coils Sales YoY (K Units), 2021-2032
Figure 90. Middle East and Africa Intracranial Embolization Coils Revenue YoY (US$ Million), 2021-2032
Figure 91. Middle East and Africa Top 5 Manufacturers Intracranial Embolization Coils Sales Revenue (US$ Million) in 2025
Figure 92. Middle East and Africa Intracranial Embolization Coils Sales Volume (K Units) by Application (2021-2032)
Figure 93. Middle East and Africa Intracranial Embolization Coils Sales Revenue (US$ Million) by Application (2021-2032)
Figure 94. GCC Countries Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 95. Turkey Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 96. Egypt Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 97. South Africa Intracranial Embolization Coils Revenue (US$ Million), 2021-2032
Figure 98. Intracranial Embolization Coils Industry Chain Mapping
Figure 99. Regional Intracranial Embolization Coils Manufacturing Base Distribution (%)
Figure 100. Global Intracranial Embolization Coils Production Market Share by Region (2021-2032)
Figure 101. Intracranial Embolization Coils Production Process
Figure 102. Regional Intracranial Embolization Coils Production Cost Structure
Figure 103. Channels of Distribution (Direct Vs Distribution)
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed